590 related articles for article (PubMed ID: 30042377)
21. Down-regulation of lncRNA snaR is correlated with postoperative distant recurrence of HPV-negative cervical squamous cell carcinoma.
Zheng Z; Gao Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30249756
[TBL] [Abstract][Full Text] [Related]
22. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
Xue KC; Hu DD; Zhao L; Li N; Shen HY
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma.
Lan X; Sun W; Dong W; Wang Z; Zhang T; He L; Zhang H
Gene; 2018 Mar; 646():98-105. PubMed ID: 29287713
[TBL] [Abstract][Full Text] [Related]
24. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.
Zhang Y; Li F; Chen J
Oncol Rep; 2019 Apr; 41(4):2511-2517. PubMed ID: 30720110
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
26. TGF-β1 upregulates the expression of lncRNA UCA1 and its downstream HXK2 to promote the growth of hepatocellular carcinoma.
Hu ML; Wang XY; Chen WM
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4846-4854. PubMed ID: 30070319
[TBL] [Abstract][Full Text] [Related]
27. LncRNA GASL1 inhibits tumor growth of non-small cell lung cancer by inactivating TGF-β pathway.
Su WZ; Yuan X
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7282-7288. PubMed ID: 30468472
[TBL] [Abstract][Full Text] [Related]
28. LncRNA POU3F3 promotes cancer cell migration and invasion in nasopharyngeal carcinoma by up-regulating TGF-β1.
Li W; Wu X; She W
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30602452
[TBL] [Abstract][Full Text] [Related]
29. LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-β1 and downregulating PHGDH.
Li Q; Gao H; Zhou S; Liao Y
Breast Cancer; 2018 Sep; 25(5):619-625. PubMed ID: 29626321
[TBL] [Abstract][Full Text] [Related]
30. LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44.
Li YQ; Wang LC; Li AX; Huang W; Song Y; Wang W
Kaohsiung J Med Sci; 2022 May; 38(5):415-424. PubMed ID: 35199939
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
[TBL] [Abstract][Full Text] [Related]
32. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
33. Long Non-Coding RNA AWPPH Promotes Postoperative Distant Recurrence in Resected Non-Small Cell Lung Cancer by Upregulating Transforming Growth Factor beta 1 (TGF-β1).
Tang L; Wang T; Zhang Y; Zhang J; Zhao H; Wang H; Wu Y; Liu K
Med Sci Monit; 2019 Apr; 25():2535-2541. PubMed ID: 30953582
[TBL] [Abstract][Full Text] [Related]
34. TGF-β1 promotes the invasion and migration of papillary thyroid carcinoma cells by inhibiting the expression of lncRNA-NEF.
Xie J; Liu Y; Du X; Wu Y
Oncol Lett; 2019 Mar; 17(3):3125-3132. PubMed ID: 30867742
[TBL] [Abstract][Full Text] [Related]
35. Expression and Function of Long Noncoding RNA NONHSAT129183 in Papillary Thyroid Cancer.
Ding J; Wang F; Xiang T; Qiao M
Oncol Res; 2018 Aug; 26(7):1047-1053. PubMed ID: 29321094
[TBL] [Abstract][Full Text] [Related]
36. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
[TBL] [Abstract][Full Text] [Related]
37. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
39. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Wang G; Sun J; Zhao H; Li H
Med Sci Monit; 2018 Oct; 24():7689-7696. PubMed ID: 30368517
[TBL] [Abstract][Full Text] [Related]
40. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
